Clinical Study
Redefining Onyx HD 500 in the Flow Diversion Era
| Case no. | Plavix 650 mg given | Balloon used | Microcatheter | Access catheter | Total volume (mL) Onyx injected (incl dead space) | Immediate angiographic Raymond scale | Immediate occlusion | Adverse events | mRS at discharge |
| 1 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.30 | Complete occlusion | 100% | No adverse events | 0 | 2 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.30 | Complete occlusion | 100% | No adverse events | 0 | 3 | No | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.50 | Complete occlusion | 100% | Required decompressive hemicraniectomy | 5 | 4 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.20 | Complete occlusion | 100% | Death | 6 | 5 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.70 | Complete occlusion | 100% | No adverse events | 0 | 6 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.60 | Small residual neck | 95–99% | Femoral access complication | 0 | 7 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 4.80 | Complete occlusion | 100% | Worsening of oculomotor deficit | 0 | 8 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.80 | Complete occlusion | 100% | TIAs | 0 | 9 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 8.40 | Complete occlusion | 100% | Worsening of oculomotor deficit | 1 | 10 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.50 | Complete occlusion | 100% | No adverse events | 0 | 11 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.85 | Small residual neck | 95–99% | TIAs | 1 | 12 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 0.43 | Complete occlusion | 100% | Transient visual disturbance | 1 | 13 | Yes | Hyperglide | Rebar 14 | 8F Guiding catheter | 2.70 | Complete occlusion | 100% | No adverse events | 1 | 14 | Yes | Hyperglide | Echelon 10 | 8F Guiding catheter | 1.40 | Complete occlusion | 100% | Asymptomatic Cervical ICA dissection | 0 | 15 | Yes | Hyperglide | Echelon 14 | 8F Guiding catheter | 1.20 | Complete occlusion | 100% | No adverse events | 0 | 16 | No | Hyperglide | Echelon 10 | 6F Guiding catheter | 0.55 | Complete occlusion | 100% | No adverse events | 5 | 17 | Yes | Hyperglide | Echelon 10 | 6F Guiding catheter | 0.35 | Complete occlusion | 100% | No adverse events | 0 | 18 | Yes | Hyperglide | Echelon 10 | 6F Guiding catheter | 0.30 | Complete occlusion | 100% | No adverse events | 0 | 19 | Yes | Hyperglide | Rebar 10 | 6F Guiding catheter | 0.40 | Complete occlusion | 100% | No adverse events | 0 | 20 | Yes | Hyperglide | Echelon 10 | 6F Guiding catheter | 0.30 | Complete occlusion | 100% | No adverse events | 0 | 21 | Yes | Hyperglide | Echelon 14 | 8F Guiding catheter | 0.40 | Complete occlusion | 100% | No adverse events | 0 |
|
|